Cookies disclaimer

Estoy de acuerdo utilizamos cookies para mejorar la experiencia de navegación del usuario y para estudiar cómo se utiliza nuestro sitio web. si navega por nuestro sitio web, estará aceptando el uso de las cookies en las condiciones establecidas en la presente política de cookies. esta política puede ser actualizada, por lo que le invitamos a revisarla de forma regular

59-14-3 - 5-Bromo-2'-deoxyuridine, 99% - 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil - 5-BrdU - H27260 - Alfa Aesar

H27260 5-Bromo-2'-deoxyuridine, 99%

Número CAS
59-14-3
Nombre Alternativo
5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil
5-BrdU

Tamaño Precio ($) Cantidad Disponibilidad
250mg 31,60
1g 83,00
5g 264,00
Añadir al carrito Añadir al presupuesto al por mayor Ver artículo

5-Bromo-2'-deoxyuridine, 99%

MDL
MFCD00006529
EINECS
200-415-9

Propiedades químicas

Fórmula
C9H11BrN2O5
Peso molecular
307.10
Punto de fusión
ca 190° dec.
Solubilidad
Soluble in water.

Aplicaciones

5-Bromo-2'-deoxyuridine (BrdU) is a thymidine analog used to label DNA. It is incorporated into newly synthesized DNA in place of thymidine during the S phase of the cell cycle. Cells that were actively proliferating can then be detected by denaturing the DNA and allowing specific antibodies to target the BrdU incorporation. Consequently 5-BrdU is used to study cell signaling and other processes that induce cell proliferation.

Notas

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.

Referencias documentales

Chen Li,; Avrum I. Gotlieb. Transforming Growth Factor-β Regulates the Growth of Valve Interstitial Cellsin Vitro. The American Journal of Pathology. 2011, 179 (4), 1746-1755 .

Yu Gui et. al. Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 2011 , 58(6), 654-662 .

Thymidine analog, preferentially incorporated into cellular DNA in place of thymidine, producing increased radiosensitivity of the cell: Int. J. Radiat. Oncol. Biol. Phys., 10, 1399 (1984); 21, 709 (1991). Mutagen used in genetic research: Mutat. Res., 258, 161 (1991). Reviews on use in diagnostics and research: Histochem. J., 27, 339, 923 (1995; 28, 531 (1996).

Indicaciones de peligro y de precaución del GHS

Indicaciones de peligro (UE): H341

Suspected of causing genetic defects.

Indicaciones de precaución: P201-P281-P202-P308+P313-P405-P501a

Obtain special instructions before use. Use personal protective equipment as required. Do not handle until all safety precautions have been read and understood. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Otras referencias

Merck
14,1452
Beilstein
30395
Código de tarifa arancelaria unificado
2934.99
TSCA
Yes
RTECS
YU7350000

Recomendado

Visto recientemente

Productos químicos

Ciencias de la vida

Metales & materiales

Catalizadores

Análisis y material de laboratorio